Developing clinical outcome measures in multiple sclerosis: an evolving process

McDowell I , Newell C. Measuring health: a guide to rating scales and questionnaires, second edition. Oxford: Oxford University Press , 1996.

Cohen JA , Cutter GR , Fischer JS , et al. Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial . Arch Neurol 2001; 58: 961-967 .

Rothwell PM , McDowell Z , Wong CK , Dorman PJ. Doctors and patients don’t agree: cross sectional study of patients’ and doctors perceptions and assessments of disability in multiple sclerosis . BMJ 1997; 314: 1580-1583 .

Kalkers NF , Bergers E , Castelijns JA , et al. Optimizing the association between disability and biological marker in MS . Neurology 2001; 57: 1253-1258 .

Hobart J , Freeman J , Thompson A. Kurtzke’s Scale revisited: the application of psychometric methods to clinical intuition . Brain 2000; 123: 1027-1040 .

Cutter GR , Baier ML , Rudick RA , et al. Development of a multiple sclerosis functional composite as a clinical trial outcome measure . Brain 1999; 122: 871-882 .

Rudick RA , Cutter G , Reingold S. The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials . Mult Scler 2002; 8: 359-365 .

Hoogervorst EL , Kalkers NF , Uitdehaag BM , Polman CH. A study validating changes in the multiple sclerosis composite . Arch Neurol 2002; 59: 113-116 .

Sharrack B , Hughes RAC. The Guy’s Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis . Mult Scler 1999; 5: 223-233 .

Rossier P , Wade DT. The Guy’s Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity . Clin Rehabil 2002; 16: 75-95 .

Hoogervorst EL , Kalkers NF , van Winsen LML , Uitdehaag BM , Polman CH. Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis . Mult Scler 2001; 7: 335-339 .

Uitdehaag BMJ , Ader HJ , Roosma TJA , de Groot V , Kalkers NF , Polman CH. MS Functional Composite: impact of reference population and interpretation of changes . Mult Scler 2002; 8: 366-371 .

Linacre JM , Heinemann AW , et al. The structure and stability of the Functional Independence Measure . Arch Phys Med Rehabil 1994; 75: 127-132 .

Kalkers NF , de Groot V , Lazeron RHC , et al. MS Functional Composite: relation to disease phenotype and disability strata . Neurology 2000; 54: 1233-1239 .

Ciccarelli O , Brex PA , Thompson AJ , Miller DH. Disability and lesion load in MS: a reassessment with MS functional composite score and 3D fast FLAIR . J Neurol 2002; 249: 18-24 .

Miller DM , Rudick RA , Cutter G , Baier M , Fischer JS. Clinical significance of the Multiple Sclerosis Functional Composite: relationship to patient-reported quality of life . Arch Neurol 2000; 57: 1319-1324 .

McFarland HF , Barkhof F , Antel J , Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis . Mult Scler 2002; 8: 40-51 .

Vickrey BG , Hays RD , Harooni R , et al. A health-related quality of life measure for multiple sclerosis . Qual Life Res 1995; 4: 187-206 .

Cella DF , Dineen K , Arnason B , et al. Validation of the functional assessment of multiple sclerosis quality of life instrument . Neurology 1996; 47: 129-139 .

Freeman JA , Hobart JC , Thompson AJ. Does adding MS-specific items to a generic measure (the SF-36) improve measurement . Neurology 2001; 57: 68-74 .

Fischer JS , LaRocca NG , Miller DM , Ritvo PG , Andrews H , Paty D. Recent developments in the assessment of quality of life in multiple sclerosis . Mult Scler 1999; 5: 251-259 .

Hobart JC , Lamping DL , Fitzpatrick R , Riazi A , Thompson AJ. The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based out come measure . Brain 2001; 124: 962-973 .

Ford HL , Gerry E , Tennant A , Whalley D , Haigh R , Johnson MH. Developing a disease-specific quality of life measure for people with multiple sclerosis . Clin Rehabil 2001; 15: 247-258 .

Riazi A , Hobart JC , Lamping D , Fitzpatrick R , Thompson AJ. Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital-based samples . J Neurol Neurosurg Psychiatry (in press).

Hobart J , Thompson A. Measurement of neurological outcomes. In Asbury AK , McKann GM , McDonald WI eds. Diseases of the nervous system. Clinical neurobiology, third edition. Philadelphia, PA: WB Saunders Co. , 105-117 (in press).

Norvedt MW , Riise T. The use of quality of life measures in multiple sclerosis . Mult Scler (in press).